Please try another search
Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing Sodium Nitroprusside injection, and Generic ANDA 2 and 3 for acute cardiology; and TARDOCAL, to treat neurological indications. It offers products through retail and mail order pharmacies. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.
Name | Age | Since | Title |
---|---|---|---|
Morris Karmazyn | - | - | Member of Scientific Advisory Board |
A. Michael Lincoff | - | 2005 | Member of Scientific Advisory Board |
Jeffrey Weitz | - | - | Member of Scientific Advisory Board |
Paul W. Armstrong | - | - | Chairman of Scientific Advisory Board |
Peter C. Quick | 67 | 2005 | Independent Director |
Pierre Theroux | - | - | Member of Scientific Advisory Board |
Stephen Hanessian | - | - | Member of Scientific Advisory Board |
Trevor Hassell | - | - | Member of Scientific Advisory Board |
Brent Fawkes | 54 | 2013 | Independent Director |
Arnold Naimark | 90 | 2000 | Independent Director |
James F. Kinley | 46 | 2011 | Director |
Albert David Friesen | 77 | 1997 | Founder, CEO & Chairman of the board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review